TCT 557: A Prospective, Multicenter, Randomized Controlled Trial Evaluating the Safety and Effectiveness of the CHORDS Cerebral Protection System During TAVR: Early Clinical Outcomes
We Recommend
Disclosures
<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker’s Bureau - Hanyu Medical,Shanghai</li><li>Royalty/Intellectual Property Rights - Hanyu Medical,Shanghai</li></ul>